Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Disease, Ageing and Cancer Prevention by Natural Products (Deadline: 22 May 2021)
- Blood–Brain Barrier (BBB) Opening and Molecular Transfer into the Brain (Deadline: 29 May 2021)
- Drug Resistance-Associated Proteins in Cancer (Deadline: 30 May 2021)
- Function of Neurotransmitter Receptors in Health and Disease (Deadline: 31 May 2021)
- Lipid-Based Drug Carriers and Nanoparticles (Deadline: 31 May 2021)
- Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression (Deadline: 31 May 2021)
- Pharmacogenomics 2.0 (Deadline: 31 May 2021)
- Artificial Intelligence and Machine Learning in Drug Development (Deadline: 31 May 2021)
- Bioactive Oxadiazoles (Deadline: 31 May 2021)
- Antioxidant and Prooxidant Properties of Flavonoids (Deadline: 10 June 2021)
- Molecular Insights of New Psychoactive Substances (NPS) (Deadline: 25 June 2021)
- Hormone Receptors and Signaling in Breast Cancer: Novel Targets and Therapeutic Challenges (Deadline: 30 June 2021)
- Biomolecules for Nanodelivery (Deadline: 30 June 2021)
- Primary Ciliary Dyskinesia: Genetics, Molecular Mechanisms, Diagnostic and Therapeutic Perspectives (Deadline: 30 June 2021)
- Exposure to Phytocannabinoids: Exploring Central Effects and Toxicity (Deadline: 30 June 2021)
- Endometriosis: Biological Targets and New Therapeutical Approaches (Deadline: 30 June 2021)
- Bioactive Molecules and Health (Deadline: 30 June 2021)
- Molecular Therapy Targeting Cancer Specific Signal Pathways (Deadline: 30 June 2021)
- The Magnificent World of Induced Pluripotent Stem Cell-Derived Cardiomyocytes (Deadline: 30 June 2021)
- Pharmacology of Chronic Pain Transmission and Its Modulation (Deadline: 20 July 2021)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity (Deadline: 29 July 2021)
- Cardiovascular Pharmacology and Interventions: Future Directions for Cardioprotection (Deadline: 30 July 2021)
- Making Bioactive Peptides Druggable – Challenges and Prospects (Deadline: 31 July 2021)
- The Diversity of Mammalian Nod-Like Receptor Functions (Deadline: 31 July 2021)
- Frontiers in Neuro-Oncology (Deadline: 31 July 2021)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers (Deadline: 31 July 2021)
- SGLT2 Inhibitors: Emerging "Magic Bullets" beyond Glycemic Control (Deadline: 31 July 2021)
- Advances in Nanostructured Materials between Pharmaceutics and Biomedicine 2.0 (Deadline: 31 July 2021)
- Molecular Interactions of Arterial Hypertension in Its Target Organs (Deadline: 31 July 2021)
- Pharmacological Strategies for Metabolic Diseases: New Evidence (Deadline: 31 July 2021)
- New Perspectives on Drugs Targeting Lipid-Transfer Proteins (Deadline: 31 July 2021)
- Pharmacological Plasticity (Deadline: 31 July 2021)
- Selective Ligands for Non-canonical DNA Structures: Do They Have a Future in Medicinal Chemistry? (Deadline: 31 July 2021)
- Pharmacology in Pain Management (Deadline: 31 July 2021)
- Strategies for Meniscus Preservation and Regeneration: From the Lab to Clinical Practice (Deadline: 28 August 2021)
- Stem Cell Biology of Myeloid Neoplasms 2.0 (Deadline: 30 August 2021)
- Advance in Drug-Drug Interactions 2.0 (Deadline: 31 August 2021)
- Protein–Protein Interactions, Latest Drug Development Advances (Deadline: 31 August 2021)
- hiPSC-Derived Cells as Models for Drug Discovery 2.0 (Deadline: 31 August 2021)
- Pharmacology of Neurodegenerative Diseases (Deadline: 31 August 2021)
- Cytotoxic Drugs in the Modern Era of Personalized Medicine: Are They Still of Value? (Deadline: 31 August 2021)
- Models of Drug Addiction: Translating Molecular Targets into Molecular Medicine (Deadline: 31 August 2021)
- Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk (Deadline: 31 August 2021)
- Biological Interactions of Bioactive Natural Products (Deadline: 31 August 2021)
- Mesenchymal Stem Cells and Their Derived Products as an Innovative Therapeutic Strategy in Acute Clinical Settings (Deadline: 15 September 2021)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis (Deadline: 26 September 2021)
- The Response to Drugs and Mechanisms of Resistance to Treatment in Severe Asthma (Deadline: 28 September 2021)
- New Drugs for Breast Cancer Treatment (Deadline: 30 September 2021)
- Oligonucleotide, Therapy, and Applications 2.0 (Deadline: 30 September 2021)
- Biological Properties of Medicinal Plants (Deadline: 30 September 2021)
- Molecular Mechanisms and Therapies for Kidney Diseases (Deadline: 30 September 2021)
- ncRNAS in Therapeutics (Deadline: 30 September 2021)
- Application Progress of Liposomes in Drug Development (Deadline: 30 September 2021)
- Molecular Mechanisms of Mood Stabilizers (Deadline: 30 September 2021)
- New Frontiers in Molecular Mechanisms and Therapies in Neurological Diseases (Deadline: 30 September 2021)
- Pulmonary Arterial Hypertension: From Genetics to Epigenetics (Deadline: 30 September 2021)
- Recent Advances in Rare Metabolic Bone Diseases (Deadline: 30 September 2021)
- Adenovirus: Enduring Toolbox for Basic and Applied Research (Deadline: 30 September 2021)
- Targeting Monoamine Oxidases: From Enzymatic Function to Pharmaceutical Use (Deadline: 30 September 2021)
- ADME of Novel Modalities Synopsis (Deadline: 12 October 2021)
- Advances in Molecular Activity of Potential Drugs (Deadline: 25 October 2021)
- Protein Structure–Function Relationships (Deadline: 25 October 2021)
- The Discovery and Development of Cisplatin (Deadline: 27 October 2021)
- Molecular Pharmacology of Fatty Acids and Fatty Acid Derivatives (Deadline: 30 October 2021)
- Beyond the Primary Infarction: Focus on Mechanisms Related to Secondary Neurodegeneration after Stroke (Deadline: 31 October 2021)
- Recent Advances in B Cells: Signal Transduction and Therapeutic Potential (Deadline: 31 October 2021)
- COVID-19 Innovative Drug Treatments: Looking Outside of Plato’s Cave (Deadline: 31 October 2021)
- Cellular Senescence and the Inflammatory Response in Health and Disease (Deadline: 31 October 2021)
- Non-coding RNAs as New Drug Targets (Deadline: 3 November 2021)
- Nutraceuticals in Human Diseases: Metabolism and Interactions (Deadline: 25 November 2021)
- The Pharmacology of Neurotransmission: Focus on Synaptic Alterations during Neurodegeneration and Treatments 2.0 (Deadline: 28 November 2021)
- Bridging the Gap between the Clinical and Regulatory Use of Plasma Rich in Growth Factors. Where Are We? (Deadline: 30 November 2021)
- The Dysbiotic Vaginal Microbiome: Pathogenesis and Therapeutic Opportunities (Deadline: 30 November 2021)
- Molecular Pathogenesis and Cellular-Based Therapies for Thrombocytopenia (Deadline: 30 November 2021)
- The Collagen Connection (Deadline: 30 November 2021)
- Curcumin Derivatives and Curcuminoids as Theranostic Agents in Alzheimer’s Disease (Deadline: 30 November 2021)
- Pharmacological Strategies for Neuroinflammation in Brain Injury (Deadline: 30 November 2021)
- Nanoformulations and Nano Drug Delivery (Deadline: 30 November 2021)
- Advances on Chelation and Chelator Metal Complexes in Medicine (Deadline: 30 November 2021)
- Recent Advances in Diabetic Liver Disease (Deadline: 30 November 2021)
- Advances in Photopharmacology (Deadline: 31 December 2021)
- Tryptophan in Nutrition and Health 2.0 (Deadline: 31 December 2021)
- STIMulating Ca2+ Homeostasis 2.0 (Deadline: 10 March 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
